CDC stock icon

VictoryShares US EQ Income Enhanced Volatility Wtd ETF
CDC

66.00 USD
+0.00
0.00%
At close Oct 17, 4:00 PM EDT
1 day
0.00%
5 days
2.17%
1 month
3.04%
3 months
7.30%
6 months
16.57%
Year to date
16.18%
1 year
18.36%
5 years
43.85%
0
Funds holding %
of 6,740 funds
–
Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

0% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]

0.82% less ownership

Funds ownership: 71.55% [Q1] → 70.73% (-0.82%) [Q2]

5% less funds holding

Funds holding: 101 [Q1] → 96 (-5) [Q2]

12% less capital invested

Capital invested by funds: $654M [Q1] → $573M (-$80.2M) [Q2]

36% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 14

67% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 51

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for CDC.

See Analyst Rankings

Financial journalist opinion

Neutral
Seeking Alpha
2 weeks ago
CDC: A Value Dividend Play For When Stocks Go Down Hard
Active management aims to beat benchmarks but often struggles; VictoryShares US EQ Income Enhanced Volatility Wtd ETF offers a disciplined, risk-managed approach focusing on high-yield, stable large-cap stocks. The CDC ETF's unique volatility-weighted methodology and ability to move to cash during market drops provide a smoother ride and potential protection against big losses. The fund's sector allocation leans towards dividend-paying sectors like Utilities, Financials, and Energy, with a lower tech allocation, offering a diversified approach.
CDC: A Value Dividend Play For When Stocks Go Down Hard
Positive
Seeking Alpha
4 months ago
CDC: Peculiar Market-Timing Strategy Incapable Of Capturing Sufficient Upside, A Hold
CDC is an index-based ETF that favors less volatile high-yield stocks. Its strategy incorporates a sophisticated market-timing ingredient. CDC offers a lesson on how safety-oriented market-timing strategies can disappoint, especially when downside and upside capture are completely out of proportion. I believe CDC has growth factor-related risks. Valuation and quality are a silver lining, yet they are not necessarily supportive of outperformance.
CDC: Peculiar Market-Timing Strategy Incapable Of Capturing Sufficient Upside, A Hold
Neutral
Business Wire
5 months ago
Clinical Trial by Harvard Pilgrim Health Care Institute, HCA Healthcare, UCI Health and CDC Identifies Strategy to Rapidly Detect and Respond to Hospital Outbreaks Using Algorithm-Driven Technology
BOSTON & NASHVILLE, Tenn. & ORANGE, Calif. & ATLANTA--(BUSINESS WIRE)--An automated tool that improves outbreak detection for hundreds of pathogens successfully served as an early warning system to find and respond to potential hospital outbreaks, as reported today in NEJM Evidence. A Trial of Automated Outbreak Detection to Reduce Hospital Pathogen Spread The large multi-state, real-world study was conducted in 82 hospitals and led by Harvard Pilgrim Health Care Institute, HCA Healthcare, Univ.
Clinical Trial by Harvard Pilgrim Health Care Institute, HCA Healthcare, UCI Health and CDC Identifies Strategy to Rapidly Detect and Respond to Hospital Outbreaks Using Algorithm-Driven Technology
Negative
Seeking Alpha
7 months ago
CDC: Revisiting This Once Top-Performing High-Dividend ETF
CDC was once a top-performing high-dividend ETF, but in 2023, it ranked dead last in the large-cap value ETF category. Past performance was not a good indicator of future results. While its long/cash strategy succeeded in 2020, the underlying portfolio has gradually lost its low-beta advantage. It's now at the same level as SCHD's, which doesn't have a volatility screen. Due to the ETF's high 0.38% expense ratio, CDC and SCHD also offer nearly identical forward dividend yields, but SCHD is a much higher-quality fund.
CDC: Revisiting This Once Top-Performing High-Dividend ETF
Negative
Seeking Alpha
9 months ago
CDC: Ineffective Momentum Strategy, No Reason To Buy
CDC generally invests in U.S. equities with above-average yields and below-average volatility. It sometimes shifts to cash, depending on market conditions. These shifts are sometimes ill-timed, leading to losses and underperformance, as has been the case YTD.
CDC: Ineffective Momentum Strategy, No Reason To Buy
Positive
Seeking Alpha
10 months ago
CDC: A Solid Market Timing ETF
VictoryShares US EQ Income Enhanced Volatility Wtd ETF seeks to track the performance of the Nasdaq Victory US Large Cap High Dividend 100 Long/Cash Volatility Weighted Index. CDC uses a complex investment approach to reduce risk, focusing on dividend-paying stocks and market timing to adjust equity exposure. The Fund has achieved very strong risk-adjusted performance historically.
CDC: A Solid Market Timing ETF
See News Rankings
Charts implemented using Lightweight Charts™